Ahmedabad-based pharmaceutical major, Cadila Healthcare Ltd (Zydus Cadila), has entered into an agreement with the World Health Organisation (WHO) to explore a possible collaboration in the development of a drug for the treatment of rabies, through the use of monoclonal antibodies.

Sharon Bio-Medici

Aurobindo Pharma, one of the leading drugmakers in India, has informed that it has received final approval from the US Food and Drug Administration (US FDA) for its Cefazolin injection in the strengths of 500 mg and 1 gram per vial.

According to the company, the injection is a Sterile Cephalosporin product under the anti-infective segment and is a generic equivalent to Abraxis Pharmaceutical Products' reference listed drug Cefazolin.

Aurobindo has 74 abbreviated new drug applications (ANDA) approved by the U. S. FDA.

Stock market analysts have maintained ‘buy’ rating on Cipla stock with an intraday target of Rs 231.

According to them, interested traders can purchase the stock around Rs 228 with a strict stop loss of Rs 225. If the stock market remains on positive track, the stock pricing becomes more attractive, and reach above Rs 232.